Liothyronine Sodium NDC 68788-7269

Product information

Brand name (proprietary)

Liothyronine Sodium

Generic name (nonproprietary)

liothyronine sodium

Active ingredients

Liothyronine sodium — 5 ug/1

Dosage form

Tablet

Route

Oral

Labeler

Preferred Pharmaceuticals Inc.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 200295

Marketing start

Jan 11, 2019

Listing expires

Dec 31, 2027

Other FDA classes

Triiodothyronine (Chemical structure)

Identifiers

Product ID 68788-7269_cb7904ed-91d9-47c1-8841-5cea1d5c9ed0SPL ID cb7904ed-91d9-47c1-8841-5cea1d5c9ed0SPL set ID 57744c7c-af44-4bc4-a5a8-79f05710f469RxCUI 903456UNII GCA9VV7D2N

Pharmacologic class

l-Triiodothyronine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468788726903 followed by a unit qualifier and the quantity Copy

Package 68788-7269-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 200295

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.